NEW YORK (GenomeWeb) – Mental health-focused genetic testing firm Genomind today said that it closed a $6 million funding round.

The latest investment bid was led by Claritas Capital, which led a $5 million financing round for Genomind in April 2014.

In a statement, Genomind said it plans to use the infusion of funds to grow the firm, conduct multisite randomized trials for the Genecept Assay pharmacogenetic service, and develop a new, expanded test offering. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.